Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep369 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Insulin regulated aminopeptidase (IRAP) inhibition affects glucose metabolism in obese pre-diabetic Zucker rats

Krskova Katarina , Balazova Lucia , Dobrocsyova Viktoria , Balogova Erika , Suski Maciej , Olszanecki Rafal , Zorad Stefan

Skeletal muscle and adipose tissue has been identified as an endocrine organ and their metabolism exerts an impact on whole-body metabolism. Endocrine functions attributed to adipokines and myokines are involved in body weight regulation and insulin sensitivity. Obesity is associated with dys-regulation of adipose tissue and skeletal muscle metabolism and is accompanied with insulin resistance. Our study investigates the effect of insulin regulated aminopeptidase (IRAP) inhibi...

ea0032p137 | Calcium and Vitamin D metabolism | ECE2013

The effects of lactose intolerance and lactose intolerance associated diseases on serum vitamin D levels, bone metabolism markers, bone mineral density and bone fractures

Csupor Emoke , Acs Bence , Acs Orsolya , Ferencz Viktoria , Meszaros Szilvia , Toth Edit , Farkas Gabor , Horvath Csaba

Introduction: Lactose intolerance itself is linked with lower peak bone mass (PBM) and with decreased bone mineral density (BMD) which may decrease further with lactose intolerance associated comorbidities. The aim of our study was to examine how bone metabolic parameters are affected (change of bone metabolism markers, BMD and frequency of fractures) in lactose intolerance which was accompanied by previously diagnosed hyperlipidemia or by hypothyroidism.<p class="abstext"...

ea0032p158 | Calcium and Vitamin D metabolism | ECE2013

Comparative study of bone metabolic parameters and vitamin D levels of fertile aged women, suffering from different bone metabolism altering diseases

Acs Orsolya , Acs BenceT , Horvath Csaba , Ferencz Viktoria , Meszaros Szilvia , Toth Edit , Csupor Emoke

Introduction: Polycystic ovary syndrome (PCOS), lactase deficiency, nephrolithisasis and thyroid diseases are considered endemic. The aim of our study was to evaluate which of the above-mentioned diseases affect the most the bone metabolic parameters, bone mineral density (BMD) and the prevalence of bone fractures in fertile aged women.Materials and methods: A total of 92 fertile aged women (32.6±5.2 years) were divided into four groups (23 in each)...

ea0020p491 | Obesity and Metabolism | ECE2009

Regulation of novel metabolic regulator fibroblast growth factor-21 by body adiposity and hypercortisolemia: studies in patients with obesity and Cushing’s syndrome

Durovcova Viktoria , Krsek Michal , Hana Vaclav , Marek Josef , Bartlova Marketa , Kavalkova Petra , Haluzik Martin

Fibroblast growth factor-21 (FGF-21) is a novel regulator of metabolic homeostasis that improved diabetes compensation and dyslipidemia in diabetic mice and monkeys. However, little is known about its regulation in humans. Cushing’s syndrome (CS) is characterized by endogenous hypercortisolism and is often associated with numerous metabolic abnormalities. The objective of this study was to test the hypothesis that CS is associated with altered levels of FGF 21 that may in...

ea0014p418 | (1) | ECE2007

The relationship between the increased body mass index and the bone fracture prevalence in postmenopausal pollen allergic women

Ferencz Viktoria , Meszaros Szilvia , Csupor Emoke , Toth Edit , Bors Katalin , Falus Andras , Horvath Csaba

Our aim was to investigate whether pollen-allergy can affect fractures in postmenopausal women. A total of 125 postmenopausal pollen-allergic women (mean age 61.26 yr) were split into four groups: treated neither with H1 histamine receptor (H1R) antagonist nor with inhaled corticosteroid (n=43), treated only with H1R antagonist (n=53), treated both with H1R antagonist and inhaled corticosteroid (n=17), treated only with inhaled corticosteroid (n=12)...

ea0014p419 | (1) | ECE2007

Decreased bone resorption in H1 histamine receptor antagonist treated allergic children

Meszaros Szilvia , Ferencz Viktoria , Bojszko Agnes , Pallinger Eva , Falus Andras , Hosszu Eva , Horvath Csaba

Histamine receptor antagonists seem to have effect on bone metabolism according to previous studies. We investigated the bone turnover in allergic children who were treated with H1 hisztamin receptor (H1R) antagonists.The biochemical bone turnover markers [β-CrossLapps (β-CTx), osteocalcin (OCN), β-CTx/OCN ratio], parathyroid hormone (PTH) and the 25-OH-vitamin D3 were determined in 37 H1R antagonist treated multiplex allergic c...

ea0073pep1.3 | Presented ePosters 1: Adrenal and Cardiovascular Endocrinology | ECE2021

Rationale for a reduced dexamethasone dosis in prenatal CAH therapy based on pharmacokinetic modelling

Reisch Nicole , Stachanow Viktoria , Neumann Uta , Blankenstein Oliver , Fuhr Uwe , Huisinga Wilhelm , Michelet Robin , Kloft Charlotte

ContextPrenatal dexamethasone (Dex) therapy is used in female foetuses with congenital adrenal hyperplasia (CAH) to suppress adrenal androgen excess and prevent virilisation of the external genitalia. The prenatal dexamethasone dose of 20 µg/kg per day has been used for decades in prenatal CAH and is associated with risks for the treated mother and potentially for the unborn child. Despite the high medical need, no prospective, clinical studies had ...

ea0081p195 | Reproductive and Developmental Endocrinology | ECE2022

The effect of dihydrotestosterone on the immune profile in a mouse model of Polycystic Ovary Syndrome

Torstensson Sara , Ascani Angelo , Lu Haojiang , Risal Sanjiv , Eriksson Gustaw , Li Congru , Benrick Anna , Obermayer-Pietsch Barbara , Stener-Victorin Elisabet

Polycystic Ovary Syndrome (PCOS) is an endocrine disorder affecting 10-15% of women worldwide, characterized by high androgen levels, anovulation and/or polycystic ovarian morphology. Chronic low-grade inflammation is associated with the disorder as well as many of its comorbidities, such as obesity and type-2 diabetes. To determine the role of the immune system in the pathophysiology of PCOS, we characterized the immune profile of the dihydrotestosterone (DHT)-induced PCOS-li...

ea0081ep871 | Reproductive and Developmental Endocrinology | ECE2022

Endometrial cell-type-specific disease signatures and endometrial organoids in polycystic ovary syndrome

Eriksson Gustaw , Li Congru , Pui Han-Pin , Risal Sanjiv , Hirschberg Angelica Linde n , Petropoulos Sophie , Deng Qiaolin , Stener-Victorin Elisabet

Introduction: Polycystic ovary syndrome (PCOS) is the leading cause of female infertility and is associated with high degree of comorbidities including type 2 diabetes and endometrial cancer. Hyperandrogenemia is a hallmark of PCOS and contributes to endometrial-related dysfunctions, including implantation failure and miscarriage. Whether cellular heterogeneity contributes to the functioning of the endometrium is not previously studied. Therefore, the aim is to reveal cell-typ...

ea0090p262 | Late-Breaking | ECE2023

Define cell-type-specific disease signatures regulating white adipose tissue of women with polycystic ovary syndrome

Li Congru , Eriksson Gustaw , Lu Haojiang , Vannay Alana , Lindgren Eva , Hirschberg Linden Angelica , Deng Qiaolin , Stener-Victorin Elisabet

White adipose tissue (WAT) is a dynamic and heterogeneous organ composed of different cell types involved in a wide array of biological processes. We know that women with polycystic ovary syndrome (PCOS) suffer from insulin resistance and type 2 diabetes which is associated with pathological white adipose tissue (WAT) function and expansion characterized by hypertrophic adipocytes, altered production and release of lipids and adipokines, and chronic low-grade tissue inflammati...